FACILITIES:
The Augusta BioBusiness Center is located in downtown Augusta at 973 and 985
Broad Street. The ABBC occupies 16,653SF with fully furnished and equipped
wet laboratory suites, dry laboratories, offices, conference rooms, cubicles
plus two employee break rooms and a mail/copy room. The ABBC is home to the
Georgia Medical Center Authority's administrative offices, plus three biotech
companies.
SERVICES:
ABBC provides a variety of services for a new
start-up company. All of these services are designed
to provide small companies with operational support,
technical know-how and fully equipped facilities
to free up time for the entrepreneur to concentrate
on developing
the new company. In most cases, GMCA is able to provide
company specific facilities and equipment through
state and local funding sources.
ABBC provides:
• Turn-key facilities for the entrepreneurs complete
with scientific laboratory equipment, office furniture,
mail room, conference room and internet and VOIP phone
services.
•
ABBC has established an agreement with MCG LSBDC to exchange
scientific equipment.
•
Access to network of area professionals and consultants.
•
Area vendors group discounts for most services.
•
Technology Transfer support.
•
Business plan and market review.
•
Pre-incubation assistance in business ideation.
•
Discounts through Preferred Providers program.
•
Access to Medical College of Georgia core labs.
•
Educational seminars and training.
•
CEO round table discussions to learn from successful area
business leaders.
•
Access to area small investors and volunteer advisors.
•
Mentoring program from area professionals and business
leaders.
•
Basic product marketability review.
ABBC seeks to attract medical device, bioinformatics,
medical software, tele-medicine, and biotech companies.
ABBC assists post-incubator companies as well as new start-ups.
Companies that have increasing revenue, but are not yet
ready to acquire their own facilities are potential licensees.
These companies will further be assisted by GMCA by issuing
bonds to aid in the acquisition or development of new R&D
or manufacturing facilities
|
